BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26872273)

  • 1. Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation.
    Girolami A; Peroni E; Girolami B; Ferrari S; Lombardi AM
    Hematology; 2016 Sep; 21(8):486-9. PubMed ID: 26872273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency.
    Girolami A; Berti de Marinis G; Bertozzi I; Peroni E; Tasinato V; Lombardi AM
    Eur J Haematol; 2013 Aug; 91(2):152-6. PubMed ID: 23621110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradoxical association between inherited factor VII deficiency and venous thrombosis.
    Marty S; Barro C; Chatelain B; Fimbel B; Tribout B; Reynaud J; Schved JF; Giansily-Blaizot M
    Haemophilia; 2008 May; 14(3):564-70. PubMed ID: 18282149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations.
    Girolami A; Cosi E; Santarossa C; Ferrari S; Lombardi AM
    Acta Haematol; 2016; 136(2):118-22. PubMed ID: 27385629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital factor XI deficiency: an update.
    Duga S; Salomon O
    Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patients.
    Girolami A; Sambado L; Bonamigo E; Ferrari S; Lombardi AM
    Lab Hematol; 2013 Dec; 19(4):17-21. PubMed ID: 24370871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of thrombosis in rare bleeding disorders.
    Ruiz-Saez A
    Semin Thromb Hemost; 2013 Sep; 39(6):684-92. PubMed ID: 23929306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two adenine insertion polymorphism in the 3' untranslated region of factor VII gene is associated with peripheral arterial disease but not with venous thrombosis. Results of case-control studies.
    Serve E; Reny JL; Akhavan S; Emmerich J; Fischer AM; Tapon-Bretaudière J
    Thromb Haemost; 2007 Oct; 98(4):733-7. PubMed ID: 17938795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XI antisense oligonucleotide for prevention of venous thrombosis.
    Büller HR; Bethune C; Bhanot S; Gailani D; Monia BP; Raskob GE; Segers A; Verhamme P; Weitz JI;
    N Engl J Med; 2015 Jan; 372(3):232-40. PubMed ID: 25482425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
    Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
    Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor XI as a novel target for antithrombotic treatment.
    Löwenberg EC; Meijers JC; Monia BP; Levi M
    J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-dependent contributions of FXII and FXI to venous thrombosis in mice.
    Grover SP; Olson TM; Cooley BC; Mackman N
    J Thromb Haemost; 2020 Nov; 18(11):2899-2909. PubMed ID: 33094904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis in rare bleeding disorders.
    Ruiz-Sáez A
    Hematology; 2012 Apr; 17 Suppl 1():S156-8. PubMed ID: 22507808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency.
    Girolami A; Candeo N; Vettore S; Lombardi AM; Girolami B
    J Thromb Thrombolysis; 2010 Apr; 29(3):299-302. PubMed ID: 19412729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in inherited factor VII deficiency.
    Mariani G; Herrmann FH; Schulman S; Batorova A; Wulff K; Etro D; Dolce A; Auerswald G; Astermark J; Schved JF; Ingerslev J; Bernardi F;
    J Thromb Haemost; 2003 Oct; 1(10):2153-8. PubMed ID: 14521598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
    Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
    Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VII Deficiency.
    Mariani G; Bernardi F
    Semin Thromb Hemost; 2009 Jun; 35(4):400-6. PubMed ID: 19598068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XI Deficiency.
    Duga S; Salomon O
    Semin Thromb Hemost; 2009 Jun; 35(4):416-25. PubMed ID: 19598070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits.
    Yau JW; Liao P; Fredenburgh JC; Stafford AR; Revenko AS; Monia BP; Weitz JI
    Blood; 2014 Mar; 123(13):2102-7. PubMed ID: 24501216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single-centre experience of 19 years.
    Ling G; Kagdi H; Subel B; Chowdary P; Gomez K
    Haemophilia; 2016 May; 22(3):411-8. PubMed ID: 26663472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.